Theresa Heggie

(Ms. Theresa Heggie)

Currently holds a position at BioCryst Pharmaceuticals Inc

Positions

Position Company Period
Director BioCryst Pharmaceuticals Inc Dec. 3, 2018 -
Senior Vice President, Head of Europe and Canada Alnylam Pharmaceuticals Inc May 9, 2017 - Jan. 1, 2018
Independent Director Swedish Orphan Biovitrum AB (publ) May 24, 2016 - April 7, 2017
Theresa Heggie's trades of BioCryst Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-06-14 2024-06-14 S Sale
6,698 -11.2%
6.11
USD 40,925
6,698 -11.2% 6.11 USD 40,925
// ... existing code ... // ... rest of the file ...